Urodynamic testing

Feb 18, 2020

Women's Excellence Offers Minimally Invasive Treatment Options for Urinary Incontinence

May 03, 2019

AUA and SUFU Release New Clinical Guideline on Urinary Incontinence after Prostate Treatment

Dec 13, 2018

Women's Excellence Offers In-Office Testing for Bladder Control Problems like Overactive Bladder and Stress Incontinence

Jul 30, 2018

BlueWind Medical Appoints Dr. Roger R. Dmochowski, MD, MMHC, as Chief Medical Officer

Apr 23, 2018

LABORIE Medical Technologies and Cogentix Medical Announce Completion of Acquisition of Cogentix Medical by LABORIE Medical Technologies

Mar 12, 2018

LABORIE Medical Technologies to acquire Cogentix Medical Inc., for $214 million

Feb 28, 2018

Urovant Sciences Announces Upcoming Presentations of Data from Phase 2b Trial of Vibegron in Patients with Overactive Bladder

Dec 06, 2017

Cogentix Medical Announces Palmetto GBA Extends Medicare Coverage on Urgent® PC

Sep 12, 2017

U.S. FDA Accepts for Review Astellas' Supplemental New Drug Application for mirabegron for Use in Combination with solifenacin succinate 5 mg for the Treatment of Overactive Bladder

Sep 01, 2017

Urinary Catheters Market Worth 2.19 Billion USD by 2022

Aug 21, 2017

Urodynamic Equipment and Consumables Market Analysis 2014 - 2025

Aug 14, 2017

Global Urodynamic Devices Market - Analysis, Technologies & Forecasts to 2021 - Key Vendors are Laborie, CooperSurgical, Verathon & Albyn Medical

Jul 27, 2017

Overactive Bladder Treatment Market Worth 4.19 Billion USD by 2022